Seeing Is Believing
with an average price target of $119.38. This is a potential upside of $5.81 (5.12%) from yesterday's end of day stock price of $113.57.
Spark Therapeutics's activity chart (see below) currently has 84 price targets and 58 ratings on display.
Analysts average stock forecasts to be materialized ratio is 96.5% with an average time for these price targets to be met of 199.31 days.
Most recent stock forecast was given by GENA WANG from BARCLAYS on 25-Mar-2019. First documented stock forecast 24-Feb-2015.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$74
$-39.57 (-34.84%)
5 years 7 months 26 days ago
(25-Mar-2019)
6/7 (85.71%)
$-39.53 (-34.82%)
203
Hold
$80
5 years 7 months 26 days ago
(25-Mar-2019)
5/5 (100%)
$23.99 (42.83%)
375
Hold
$65
$-48.57 (-42.77%)
$65
5 years 8 months 24 days ago
(27-Feb-2019)
5/6 (83.33%)
$-48.4 (-42.68%)
212
Hold
$72
5 years 8 months 25 days ago
(26-Feb-2019)
6/6 (100%)
$16.24 (29.12%)
280
Hold
5 years 8 months 26 days ago
(25-Feb-2019)
6/6 (100%)
$46.99 (83.90%)
465
What is ONCE (Spark Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on ONCE (Spark Therapeutics) with a proven track record?
Which analyst has the most public recommendations on ONCE (Spark Therapeutics)?
Which analyst is the currently most bullish on ONCE (Spark Therapeutics)?
Which analyst is the currently most reserved on ONCE (Spark Therapeutics)?